Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma. uri icon

authors

  • Huntington, Scott F
  • von Keudell, Gottfried
  • Davidoff, Amy J
  • Cary Gross, MD
  • Prasad, Sapna A

publication date

  • January 1, 2018